Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peroxisomal disorders: a review

B Fournier1, J A Smeitink, L Dorland

  • 1University Children's Hospital, Wilhelmina Kinderziekenhuis, Department of Metabolic Diseases, Utrecht, The Netherlands.

Journal of Inherited Metabolic Disease
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Aggregatibacter actinomycetemcomitans infection in children: two case reports and a review of the literature.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2024
Same author

Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Corrigendum to "Mitochondrial and cytosolic thiol redox state are not detectably altered in isolated human NADH:ubiquinone oxidoreductase deficiency" [Biochim. Biophys. Acta. 2007;1772(9):1041-1051. PMID: 17600689].

Biochimica et biophysica acta. Molecular basis of disease·2021
Same author

Oral manifestations of sickle cell disease.

British dental journal·2019
Same journal

Biallelic Loss-Of-Function Variant in ATP5ME Is Associated With Severe and Early Onset Oxidative Phosphorylation Deficiency.

Journal of inherited metabolic disease·2026
Same journal

Beyond Upper Airway Involvement: Evidence of Intrinsic Lung Disease in a Mouse Model of Mucopolysaccharidosis I.

Journal of inherited metabolic disease·2026
Same journal

Immune Dysregulation in Branched Chain Organic Acidemias.

Journal of inherited metabolic disease·2026
Same journal

Long Term Follow-Up After Transplantation in Propionic Acidemia: A Retrospective French Pediatric and Adult Cohort Study.

Journal of inherited metabolic disease·2026
Same journal

Tri-Parametric Assessment of α-Galactosidase A Activity, lysoGb3 and X-Inactivation Aids Genotype-Phenotype Categorization of Fabry Disease Female Patients.

Journal of inherited metabolic disease·2026
Same journal

Mapping the Severity of Phenylalanine Hydroxylase Deficiency.

Journal of inherited metabolic disease·2026
See all related articles

Peroxisomal disorders, once thought rare, now encompass 17 human diseases. A new classification distinguishes between peroxisome assembly deficiencies and single enzyme defects, aiding diagnosis and research.

Area of Science:

  • Biochemistry
  • Genetics
  • Cell Biology

Background:

  • Peroxisomal disorders were historically considered rare, with limited diagnostic methods.
  • Currently, 17 distinct human disorders are associated with peroxisomal dysfunction.
  • Heterogeneity in clinical, biochemical, and morphological aspects necessitates a combined diagnostic approach.

Purpose of the Study:

  • To propose a novel classification for peroxisomal disorders.
  • To integrate biochemical impairment severity with peroxisome assembly status.
  • To guide future research in peroxisomal disease pathophysiology.

Main Methods:

  • Review of clinical, biochemical, and morphological data.
  • Analysis of peroxisome assembly defects versus single enzyme deficiencies.

Related Experiment Videos

  • Integration of genetic analysis and peroxisomal targeting signal research.

    • Main Results:

    • A proposed classification system for peroxisomal disorders.
    • Distinction between disorders with peroxisome assembly deficiencies and single enzyme deficiencies.
    • Discussion of clinical onset, major symptoms, and recent findings.

    Conclusions:

    • Combined analysis of clinical, biochemical, and morphological data is crucial for accurate diagnosis.
    • The proposed classification aids in understanding peroxisomal disease pathophysiology.
    • Advances in genetic analysis and peroxisome biogenesis research are ongoing.